Nexus Medical Labs receives FDA Emergency Use Authorization for SARS-CoV-2 test using the RHINOstic™ Automated Nasal Swab from Rhinostics

By | May 27, 2022
Rhinostics Inc. and Nexus Medical Labs recently received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a molecular SARS-CoV-2 test enabling unsupervised self-collection.